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Yersinia pestis is one of the most virulent bacteria identified. It is the causative agent of
plague—a systemic disease that has claimed millions of human lives throughout history.
Y. pestis survival in insect and mammalian host species requires fine-tuning to sense and
respond to varying environmental cues. Multiple Y. pestis attributes participate in this
process and contribute to its pathogenicity and highly efficient transmission between
hosts. These include factors inherited from its enteric predecessors; Y. enterocolitica
and Y. pseudotuberculosis, as well as phenotypes acquired or lost during Y. pestis
speciation. Representatives of a large Enterobacteriaceae Ail/OmpX/PagC/Lom family of
outer membrane proteins (OMPs) are found in the genomes of all pathogenic Yersiniae.
This review describes the current knowledge regarding the role of Ail in Y. pestis
pathogenesis and virulence. The pronounced role of Ail in the following areas are
discussed (1) inhibition of the bactericidal properties of complement, (2) attachment and
Yersinia outer proteins (Yop) delivery to host tissue, (3) prevention of PMNL recruitment
to the lymph nodes, and (4) inhibition of the inflammatory response. Finally, Ail homologs
in Y. enterocolitica and Y. pseudotuberculosis are compared to illustrate differences that
may have contributed to the drastic bacterial lifestyle change that shifted Y. pestis from an
enteric to a vector-born systemic pathogen.
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Yersinia pestis—BRIEF CHARACTERISTICS OF A
MOST NOTORIOUS PATHOGEN
Y. pestis is a Gram negative, non-motile, facultative anaerobic
rod that exhibits bipolar staining (classic safety-pin pattern). It
is a zoonotic pathogen and the causative agent of plague—a sys-
temic disease that has claimedmillions of human lives throughout
history. The infectious dose is extremely low, estimated between
1 and 10 organisms, making it one of the most virulent bacte-
ria identified (Perry and Fetherston, 1997). In its sylvatic cycle,
Y. pestis moves between fleas (the arthropod vector) and rodents
(reservoir host) with transmission occurring when the vector
takes a blood meal. A state of high bacteremia in the mam-
malian host at the time of the bite is required for a flea infection.
Rarely, the disease can be spread through direct contact between
infected animals (Wimsatt and Biggins, 2009). Flea-borne Y. pestis
infection in humans leads to the development of bubonic and sep-
ticemic plague that can progress to secondary pneumonic plague
(Perry and Fetherston, 1997; Sebbane et al., 2006). This airborne
form of the disease can be transmitted directly between humans
without the vector involvement, causing primary pneumonic
disease. Human-to-human airborne infection is of special impor-
tance because of the rapid spread and progression of the disease
(short incubation period up to 2–3 days), and very high mortal-
ity rates (approaching 100% if untreated) (Perry and Fetherston,
1997). The characteristics of pneumonic plague highlight the
sobering potential for Y. pestis employment as a biological warfare
agent.
Phylogenetic analyses indicate Y. pestis evolved rela-
tively recently (within the last 20,000 years) from Yersinia
pseudotuberculosis, an enteropathogen that causes self-limiting
infections (Achtman et al., 1999, 2004; Skurnik et al., 2000).
Even though the bacterial genomes shares >90% similarity,
the disease transmission, course of the infection, morbidity,
and mortality are dramatically different (Bercovier et al., 1980;
Eppinger et al., 2007). One of the reasons Y. pestis is so efficient is
tight expression control of specific genes in response to the host
environment. Characteristic host cycling of Y. pestis is reflected
in global genetic responses in which temperature and calcium
ions are key environmental cues the organism senses (Perry and
Fetherston, 1997). This is facilitated by virulence phenotypes
common with Y. pseudotuberculosis and Y. enterocolitica, as well
as the acquisition of new determinants due to genetic acquisition
and genomic entropy (Ben-Gurion and Shafferman, 1981;
Perry and Fetherston, 1997; Parkhill et al., 2001; Moran, 2002;
Anisimov et al., 2004; Chain et al., 2004, 2006; Darby et al., 2005;
Erickson et al., 2006, 2008; Montminy et al., 2006; Sebbane et al.,
2006, 2009; Derbise et al., 2007; Lathem et al., 2007; Hinnebusch
and Erickson, 2008; Sun et al., 2008).
The Ail/OmpX/PagC/Lom family is a family of outer mem-
brane proteins (OMPs) found in organisms like Y. enterocolit-
ica (Ail), Y. pseudotuberculosis (Ail), Salmonella enterica serovar
typhimurium (Rck, PagC), or Escherichia coli (OmpX). Particular
members of the family are responsible for conferring resistance
to complement-mediated killing, survival in macrophages, and
adhesion and invasion of host cells (Miller et al., 1989a; Bliska
and Falkow, 1992; Heffernan et al., 1992; Cirillo et al., 1996).
Y. pestis Ail protein (also known as OmpX) has been found
to be an important virulence factor during plague pathogenesis
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(Kolodziejek et al., 2010; Hinnebusch et al., 2011). Although
our laboratory first designated this protein as OmpX, accord-
ingly to the annotations in the Y. pesis KIM genome, due to
the subsequent and common use by others of the designation
“Ail” we refer to the protein as Ail, rather than OmpX, in this
review.
The prominent role of Ail in serum resistance (Kolodziejek
et al., 2007, 2010; Bartra et al., 2008), adhesion to and internal-
ization into host cells (Kolodziejek et al., 2007, 2010; Felek and
Krukonis, 2009; Tsang et al., 2010), Yersinia outer proteins (Yop)
delivery (Felek and Krukonis, 2009; Tsang et al., 2010; Yamashita
et al., 2011), and inhibition of inflammatory response has been
shown (Felek and Krukonis, 2009; Hinnebusch et al., 2011).
This review is a compendium of the current knowledge of the
roles of Ail in Y. pestis pathogenesis and virulence. Similarities
between Ail from Y. enterocolitica and Y. pseudotuberculosis are
shown to illustrate functional similarity and differences between
the proteins. The characteristics of the Y. pestis strains used in the
studies described below are included in Table 1 to help the reader
follow the rational for particular strain use.
PRIMARY, SECONDARY, AND TERTIARY STRUCTURE OF AIL
The genome of Y. pestis KIM encodes four homologs of the Ail
protein: y1324, y1682, y2034, and y2446 (designated YPO2905,
YPO2506, YPO2190, YPO1860, accordingly in Y. pestis CO92
genome), which are also present in Y. pseudotuberculosis genome.
The gene designated y1324 encodes a protein with a predicted
molecular mass of 17.47 kDa (without the signal sequence) and
shares the highest amino acid sequence similarity to an Ail pro-
tein from Y. enterocolitica (∼70%) (Kolodziejek et al., 2007; Bartra
et al., 2008) (Figure 1).
Analysis of the ail nucleotide sequence reveals differences
among the Y. pestis isolates that result in amino acid variation
in the polypeptide chain (Eroshenko et al., 2010). Two variable
sites in the gene can be identified: (1) a missense mutation in
position 376 that results in a codon change from GTT to TTT
and consequently a substitution of Val126 (Y. pestis Pestoides
F, Angola, Y. pestis subsp. caucasica, altaica, hissarica) to Phe
(Y. pestisKIM, CO92, Antiqua,Nepal 516, Y. pestis subsp. ulegeica)
(2) insertion of an AGT triplet at position 406 that results in the
addition of an extra Ser137 in the Ail polypeptide chain (Y. pestis
Pestoides F, Y. pestis subsp. caucasica) (Figure 1).
Bioinformatic analysis of the y1324 gene also reveals two
potential products differing in the length of the signal sequence
peptide (predicted 38 and 26-residues long). The exact transla-
tional start sites have not been confirmed, but due to the lack of a
clear ribosomal binding site and less preferable GTG codon start
for the 38-residue long signal sequence peptide, the translational
start resulting in the shorter signal sequence is preferable. The sig-
nal peptide cleavage site is located between Ala and Glu and has
been identified by both bioinformatic and peptide ion mapping
analysis (Kolodziejek et al., 2007) (Figure 1).
Ail is a small, monomeric, surface-associated protein local-
ized in the OM (Pieper et al., 2009a). The crystal structure
of Yersinia pestis Ail is available (Figure 2). It reveals that Ail
forms an eight-stranded antiparallel β-barrel with four extracel-
lular loops (Figure 2). The amino acid similarity to the members
of the Ail/Lom/OmpX family is the highest for the transmem-
brane regions with little sequence conservation in the extra-
cellular loops (Bartra et al., 2008; Yamashita et al., 2011). No
obvious channel through the barrel in the tertiary model can
be found (Yamashita et al., 2011). A hydrophobic cleft and two
regions with positive charge found on the extracellular surface
are indicated to participate in Ail-conferred adhesion to sub-
strates (Yamashita et al., 2011). The NMR and CD (circular
dichroism) structural studies also confirm that Ail adopts a trans-
membrane β-barrel in micells and lipid bilayers (Plesniak et al.,
2011).
Table 1 | Characteristics and virulence of selected Y. pestis strains used in laboratory studies.
Strain pgm∗ pCD1∗∗ pMT1 pPCP Infection route LD50 mice (References) LD50 rats (References)
Y. pestis + + + + i.n. 2 × 104 1.2 × 103
CO92 (Airhart et al., 2008) (Kolodziejek et al., 2010)
s.c. 1.7 <50
(Welkos et al., 1997) (Hinnebusch et al., 2011)
Y. pestis − + + + s.c. > 107 –
KIM5 (Une and Brubaker, 1984)
i.v. 15 –
(Une and Brubaker, 1984)
Y. pestis − − + + s.c. > 107 –
KIM6 (Une and Brubaker, 1984)
i.v. > 107 –
(Une and Brubaker, 1984)
Y. pestis + − + + s.c. > 107 –
KIM6+ (Une and Brubaker, 1984)
i.v. > 107 –
(Une and Brubaker, 1984)
∗ , biofilm-related loci; ∗∗, encodes Type Three Secretory System (T3SS). i.n., intranasal; s.c., subcutaneous; i.v., intravenous.
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FIGURE 1 | Multiple strain sequence alignment and amino acid analysis
of Ail. Gray letters indicate the signal sequence and the arrow indicates the
signal sequence cleavage site (Kolodziejek et al., 2007). EL1, EL2, EL3, and
EL4 designate extracellular loops; dotted line boxes indicate extracellular
regions, including just the residues connecting two β strands (solid line
boxes), as predicted from the crystal structure by Yamashita et al. (2011).
Amino acid variation in the Ail polypeptide among Y. pestis strains is
indicated by the presence of Val in the position 126 (Y. pestis Pestoides F,
Angola, Y. pestis subsp. caucasica, altaica, hissarica) instead of Phe and
additional substitution of Ser in the position 137 (Y. pestis Pestoides F,
Y. pestis subsp. caucasica) (Eroshenko et al., 2010). Alignments of Ail
from Y. pestis (y1324) with Ail from Y. pseudotuberculosis IP 32953,
Y. enterocolitica 8081c, and three other Y. pestis Ail homologs (y1682, y2446,
and y2034) are depicted. Indicated colors represent identical,
strongly, and weakly similar residues. Alignments were produced with
ClustalW.
FIGURE 2 | Crystal structure of Ail. Extracellular loops are indicated EL1,
EL2, EL3, and EL4 and the hydrophobic belt is indicated in color. The tips of
EL2 and EL3 are disordered and these regions are marked with dotted lines
(Yamashita et al., 2011). The figure was generated from the PDBe Protein
Data Bank in Europe.
REGULATION OF AIL EXPRESSION
Ail is the most highly transcribed gene in the entire Y. pestis
transcriptome (Chauvaux et al., 2007, 2011) and the protein
encompasses ∼20–30% of the total OM proteome when the
bacterium is grown at 37◦C, the optimal temperature for Ail
expression (Myers-Morales et al., 2007; Pieper et al., 2009a,b).
The protein is still abundant, but expressed at lower levels at
ambient temperature (28◦C) (Kolodziejek et al., 2007; Bartra
et al., 2008; Pieper et al., 2009a,b) and the expression is minimal
at 6◦C (Bartra et al., 2008). The label-free comparative proteome
strategy used to identify new virulence targets reveals that Ail clus-
ters together with plasmid pCD1 virulence-associated proteins;
the protein displays a similar pattern of expression and abundance
shown for YopD, a secreted effector protein that is part of the type
three secretion system (T3SS) (Hixson et al., 2006). Transcription
of Ail can be also altered due to the mutagenesis of other OM
components. Studies show that Ail is down-regulated at 26◦C, but
not at 37◦C, when Braun lipoprotein is deleted (Galindo et al.,
2010).
Significant presence of Ail in Y. pestisOM at ambient tempera-
ture is in contrast to Ail expression in Y. enterocolitica in which the
protein is expressed at very low levels at this temperature (Bliska
and Falkow, 1992; Pierson and Falkow, 1993). Additionally, the
overall comparison of the ail transcriptional pattern in Y. pestis
and Y. pseudotuberculosis reveals that the expression of ail in
Y. pestis is at a much higher level than in Y. pseudotuberculo-
sis (Chauvaux et al., 2011). This implies that the two organism,
despite the almost identical gene sequence, use the Ail in a dif-
ferent manner depending on the physiological requirements and
this could potentially explain some differences in pathogenicity
between the two (Chauvaux et al., 2011).
AIL CONFERS SERUM RESISTANCE IN Y. pestis
Complement-dependent bacterial killing is one of the first lines
of innate immunity against pathogens (Tedesco, 2008). Thus,
resistance to serum complement is an essential phenotype for
bacterial survival in blood. Y. pestis transmission between insect
andmammalian species is determined by continual contact of the
bacteria with blood components (Perry and Fetherston, 1997).
Y. pestis can resist the bactericidal effects of serum when it is
grown at 26◦C and 37◦C, but not at 6◦C (Anisimov et al., 2005).
These temperatures correlate with ambient, mammalian core
body, and insect hibernation conditions, respectively (Anisimov
et al., 2005); and complement resistance reflects Ail expression
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pattern (Bartra et al., 2008). Out of four Ail/OmpX homologs
encoded in the Y. pestis genome, only y1324 confers resistance to
human serum. Deletion of this gene results in a rapid, essentially
100% loss of serum resistance (Kolodziejek et al., 2007; Bartra
et al., 2008). This loss is attributed to the action of complement
because heat-inactivated serum does not have lethal properties
(Kolodziejek et al., 2007; Bartra et al., 2008). Additionally, the
ail gene confers resistance to complement killing by rat, goat,
sheep, rabbit, and guinea pig sera (Bartra et al., 2008; Kolodziejek
et al., 2010). Interestingly, complement-killing of the Ail dele-
tion mutant is not observed when the bacteria are incubated
with mouse sera (Bartra et al., 2008; Kolodziejek et al., 2010);
phenomenon observed with a number of common microorgan-
isms that can be killed by sera of other species, but remain
resistant to murine sera (Marcus et al., 1954; Kolodziejek et al.,
2010). The limited bactericidal activity of murine sera remains
unclear.
Ail expressed in a bacterial host other thanY. pestis (e.g., E. coli)
confers serum resistance independently from other Y. pestis pro-
teins or LPS (Bartra et al., 2008; Kolodziejek et al., 2010).
However, serum resistance does depend on the LPS core structure
of the organism in which Ail is being expressed (Figure 3). This
can be inferred from indirect and direct evidence. The indi-
rect evidence comes from the observation that Y. pestis strains
that have shortened LPS core, through directed mutagenesis or
as a results of spontaneous mutations, have altered sensitivity
to human serum (Anisimov et al., 2005; Knirel et al., 2006,
2007; Dentovskaya et al., 2011) (Figure 3B). Y. pestis full-length
LPS inner core, composed of six residues, is required for resis-
tance to human complement, while the outer core monosac-
charides do not play a critical role (Dentovskaya et al., 2011).
The direct evidence is from the study employing a series of
isogenic Ail-expressing E. coli mutants each with progressively
truncated LPS (Figure 3C). Both the inner and outer core are
required for effective resistance to the bactericidal effect of com-
plement in E. coli as only Ail-expressing E. coli with the full
core length are resistance to complement (Kolodziejek et al.,
2010).
The observed amino acid variation in the Ail polypeptide
chain between different Y. pestis isolates (see “Primary, secondary,
FIGURE 3 | Correlation of E. coli and Y. pestis LPS structures and
Ail-mediated phenotypes—schematic representation (Kolodziejek et al.,
2010). (A) Key to LPS moieties. (B) LPS core structure of Y. pestis KM260
grown at ambient temperature; arrows indicate truncation of the core
residues that resulted in loss of serum resistance (Knirel et al., 2007;
Dentovskaya et al., 2011). (C) LPS structures of E. coli K-12 D21 and its
isogenic mutants (Yu and Mizushima, 1982; Nikaido and Vaara, 1985; Razatos
et al., 1998; Junkes et al., 2008; Prokhorenko et al., 2009). †, some sources
indicate galactose (Junkes et al., 2008); ‡, some sources indicate two or
three KDO residues (Nikaido and Vaara, 1985). The table shows presence (+)
or lack (−) of Ail-mediated phenotypes (autoaggregation and pellicle
formation, adhesion to Hep-2 cells, internalization into Hep-2 cells, and
human serum resistance) related to a particular strain (Kolodziejek et al.,
2007, 2010).
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and tertiary structure of Ail” section) seems to be insignificant
for the mediation of serum resistance, as all strains were similarly
resistant to normal rabbit serum (Eroshenko et al., 2010).
The protection of Y. pestis by Ail at either 28 or 37◦C con-
trasts with Y. enterocolitica Ail, which confers this trait only at
37◦C, reflecting temperature regulation of Ail expression in that
organism (Bliska and Falkow, 1992; Pierson and Falkow, 1993).
It has been shown that Ail in Y. pseudotuberculosis also confers
serum resistance when bacteria are grown at 37◦C (Yang et al.,
1996). In Y. enterocolitica and Y. pseudotuberculosis three factors
contribute to serum resistance: Ail, YadA, and O-chain in LPS
(Wachter and Brade, 1989; Bliska and Falkow, 1992; Pierson and
Falkow, 1993; Yang et al., 1996; Biedzka-Sarek et al., 2005; Heise
and Dersch, 2006). Y. pestis does not express YadA or O-chain
due to mutations inactivating both the yadA and several genes
in the O-chain biosynthetic gene cluster (Rosqvist et al., 1988;
Skurnik et al., 2000; Prior et al., 2001); thus they cannot play
any role in Y. pestis serum resistance. Hence, acquisition of Ail-
mediated serum resistance at lower temperatures might have been
a necessity for the passage of bacteria between mammalian and
flea hosts. Although no studies on the mechanisms of serum resis-
tance conferred by Y. pestis Ail have been published yet, based on
the literature on Ail from Y. enterocolitica and Y. pseudotubercu-
losis it is plausible that the protein binds negative regulators of
alternative (factor H), and classical and lectin [C4b-binding pro-
tein (C4BP)] complement pathways thus preventing complement
attack (Biedzka-Sarek et al., 2008a,b; Kirjavainen et al., 2008; Ho
et al., 2012).
ROLE OF AIL IN Y. pestis ADHESION TO MAMMALIAN CELLS
Adherence to host tissues is an important infection-determining
factor used by many bacterial pathogens (Reid and Sobel, 1987).
The most favorable conditions for Y. pestis adherence to host
cells in vitro is pre-incubation of bacteria at ≤28◦C in neutral
pH (Felek et al., 2010). Of three major adhesins found among
the enteropathogenic Yersiniae, two, YadA and Invasin, are not
produced by Y. pestis due to pseudogenes (Rosqvist et al., 1988;
Simonet et al., 1996; Forman et al., 2008). PsaA (pH 6 antigen)
(Yang et al., 1996; Liu et al., 2006; Felek et al., 2010) and YapE
(Lawrenz et al., 2009) are common for Y. pseudotuberculosis and
Y. pestis, have adhesive properties, and their role in adherence
was shown in Y. pseudotuberculosis (PsaA) and Y. pestis (PsaA
and YapE). However, a series of studies now show that the pri-
mary adhesin in Y. pestis is Ail. Deletion of Ail greatly reduces
binding of the bacterium to epithelial (HEp-2) and monocytic
(THP-1) cells (Kolodziejek et al., 2007; Felek andKrukonis, 2009).
Moreover, Ail-expressing E. coli facilitates binding to both cell
lines, independent from other Y. pestis components (Felek and
Krukonis, 2009; Kolodziejek et al., 2010); but, similarly to serum
resistance, this phenotype depends on the LPS background in
which Ail is expressed (Kolodziejek et al., 2010) (Figure 3C).
Recent findings indicate that the 3rd extracellular loop of Ail is
important for Ail-mediated binding to host cells (Tsang et al.,
2012). Ail-conferred adhesiveness correlates with the bacterial
autoaggregation, another phenotype mediated by the protein (see
section “Ail and autoaggregation of Y. pestis” below) (Kolodziejek
et al., 2007, 2010).
Most importantly, binding of Y. pestis to host cells via Ail, pro-
motes Yop delivery into the primary target of T3SS—the phago-
cytic cells, as well as into epithelial cells (Felek and Krukonis,
2009; Yamashita et al., 2011). Pretreatment of host cells (HEp-2)
with anti-Ail serum and deletion of Ail in Y. pestis KIM5 impair
Yop delivery, a step critical for Y. pestis pathogenesis (Felek and
Krukonis, 2009; Yamashita et al., 2011). The significant delay in
Yop delivery by an ail-negative mutant is observed in both cell
lines (HEp-2 and THP-1), particularly obvious after the first 2 h
of infection. Around 90% of Y. pestis KIM5-infected cells indi-
cate cytotoxic characteristic due to the delivery of Yops vs. only
5–10% of the cells infected with the ail-negative strain. However,
after 8 h of the infection this difference diminishes to only∼15%,
which indicates that ail-negative strain is not completely devoid
of Yop delivery capabilities (Felek and Krukonis, 2009).
Noteworthy, Y. pestis Ail shares functional homology in adher-
ence with Ail in Y. enterocolitica, but not with the Ail homolog
of Y. pseudotuberculosis (Bliska and Falkow, 1992; Yang et al.,
1996). Functional discrepancies between Ail from Y. pestis and
Y. pseudotuberculosis call for further investigation to establish that
several amino acid substitutions can lead to the dramatic change
in function and if other species-specific factors, like LPS, influ-
ence the functional differences. In contrast to Y. enterocolitica Ail
that confers adhesion when bacteria are grown at 37◦C (Bliska
and Falkow, 1992), Ail in Y. pestis can confer this phenotype when
grown at both 28 and 37◦C (Kolodziejek et al., 2007; Felek et al.,
2010).
AIL INTERACTIONS WITH THE COMPONENTS OF
EXTRACELLULAR MATRIX (ECM)
Ail-mediated binding of Y. pestis or E. coli to the regions between
the host cells during in vitro cell culturing indicates that the pro-
tein also interacts with the components of the ECM (Kolodziejek
et al., 2007; Felek and Krukonis, 2009; Tsang et al., 2010;
Yamashita et al., 2011). Purified Ail and Ail-expressing E. coli bind
specifically to laminin, fibronectin, negatively charged HSPGs,
but not collagen I or IV (Tsang et al., 2010; Yamashita et al.,
2011). In vitro models employing human cell lines and Y. pestis
show that the bacterium binds to fibronectin and laminin via Ail
(Tsang et al., 2010; Yamashita et al., 2011); however, Ail is not
the only protein that participates in binding of fibronectin by
Y. pestis (Tsang et al., 2010). These interactions are responsible
for Y. pestis attachment to host cells (see above in section “Role
of Ail in adhesiveness of Y. pestis mammalian cells”). Structural
and adhesion (employing purified Ail and Ail-expressing E. coli)
studies, show that Ail specifically binds a 40 kDA laminin frag-
ment called LG4-5 (Laminin G-like domains 4 and 5) although
other laminin domains can also facilitate the adhesion process
(Yamashita et al., 2011). Recent studies by Tsang et al. identi-
fied that Ail mediates bacterial binding to the centrally located
120 kDA fragment of fibronectin, more precisely to 9FNIII mod-
ule neighboring the RGD site present in 10FNIII region (Tsang
et al., 2012).
Disruption of Ail interaction with both laminin (Yamashita
et al., 2011) and fibronectin (Tsang et al., 2010; Yamashita et al.,
2011) alleviate Yop delivery into mammalian cells. Even though
Ail interaction with laminin is stronger than with fibronectin
Frontiers in Cellular and Infection Microbiology www.frontiersin.org August 2012 | Volume 2 | Article 103 | 5
Kolodziejek et al. Yersinia pestis Ail
in the abiotic models (protein coated glass), it is the binding to
fibronectin that contributes to increased Yop delivery into the
host cells (HEp-2). The pretreatment of the host cells with anti-
laminin antibodies itself does not inhibit Yop delivery; however,
a combination of both antibodies, anti-fibronectin, and anti-
laminin have a synergistic effect and significantly decreases cyto-
toxicity compared to treatment with anti-fibronectin antibody
alone (Yamashita et al., 2011).
It was also suggested that Ail-mediated interaction of Y. pestis
with epithelial cells involve heparin sulfate proteoglycan (Zhang
et al., 2008). X-ray diffraction crystal structure studies revealed
two binding sites for sucrose octasulfate (SOS), a smaller heparin
analog, that corresponds to two positively charged sites found on
the Ail molecule (Yamashita et al., 2011), designated HBS-I and
HBS-II (heparin-binding site 1 and 2, respectively). The HBS-I
is the primary binding site for SOS and is located on the extra-
cellular surface on the outside of the β-barrel. Extracellular loops
2 and 3 contribute residues to formHBS-I while extracellular loop
1 contributes to form HBS-II. Mutations in these regions show
weak binding to heparin (Yamashita et al., 2011). No studies on
the role of Ail-HPSG interactions and delivery of Yop have been
done.
ROLE OF AIL IN INVASIVENESS OF Y. pestis INTO
NON-PROFESSIONAL PHAGOCYTIC CELLS
Bacterial invasiveness is another mechanism to circumvent host
immune response (Hess et al., 2001). Y. pestis is a faculta-
tive intracellular pathogen that resides both inside and out-
side of the host cells during infection (Perry and Fetherston,
1997). Although macrophages and dendritic cells are the target
host cells for Y. pestis (Marketon et al., 2005), internalization
into non-professional phagocytes occurs (Cowan et al., 2000).
Work by Cowan et al. found that Y. pestis is highly invasive in
HeLa cells when grown at 26, but not at 37◦C (Cowan et al.,
2000). Deletion of Ail results in impaired internalization of
Y. pestis (∼60-fold decrease) by human epithelial cells (HEp-2)
(Kolodziejek et al., 2007), although the invasive properties of
y1324 were not confirmed by Felek et al. (Felek and Krukonis,
2009). When expressed in E. coli, Ail confers internalization
independently from other Y. pestis proteins or LPS, but the effi-
ciency of internalization depends on the LPS core background in
which the protein is expressed. Progressive truncation of LPS core
results in progressive decrease in Ail-conferred internalization of
E. coli (Figure 3C). The most pronounced effect is seen with the
Ail-expressing deep rough strain that can readily attach to the
epithelial cells, but cannot invade them (Kolodziejek et al., 2010).
Y. pestis Ail shares functional homology in invasiveness with
Ail from Y. enterocolitica (Miller and Falkow, 1988) but not with
Ail from Y. pseudotuberculosis (Yang et al., 1996) (for discus-
sion of the functional discrepancies see “Role of Ail in Y. pestis
adhesion to mammalian cells”). In contrast to enteropathogenic
Yersiniae that posses in their repertoire other proteins involved in
cellular uptake (invasin and YadA) (Isberg et al., 1987; Eitel and
Dersch, 2002), ail is the only gene that is both common within
the genus and shown to be involved in internalization of Y. pestis
(while the Pla protease-encoding plasmid pPCP1 was shown to
mediate Y. pestis internalization (Cowan et al., 2000), it is not
present in other Yersiniae). YadA structural homolog, YadBC was
found to be moderately involved in Y. pestis uptake, but its role in
Y. pseudotuberculosis is not known and the gene is not present in
Y. enterocolitica (Forman et al., 2008).
AIL AND AUTOAGGREGATION OF Y. pestis
The autoaggregation phenotype is often attributed to biofilm for-
mation on abiotic and biotic surfaces in many bacteria and is
associated with circumvention of the host defense mechanisms
during infection. The autoaggregation phenotype expressed by
pellicle formation at the air-liquid interface and by flocculent
growth is characteristic for Y. pestis and is connected to virulence
(Laird and Cavanaugh, 1980; Kolodziejek et al., 2010). It can be
observed at 28 and 37◦C (Kolodziejek et al., 2007), but not at
6◦C (author’s observation) which correlates nicely with the pat-
tern of Ail expression (Bartra et al., 2008). Indeed, deletion of Ail
confers loss of these characteristics when the bacterium is grown
in LB medium (Kolodziejek et al., 2007). Ail-induced autoaggre-
gation does not contribute to serum resistance (by making the
bacterial cells inaccessible to complement components), but it is
critical for effective bacterial adherence (Kolodziejek et al., 2007,
2010). Y. pestis ail-negative mutants that have lost the autoag-
gregation phenotype and E. coli expressing Ail, but showing no
flocculent growth, have impaired ability to adhere to epithelial
cells (Kolodziejek et al., 2010). Also, the Ail-conferred autoaggre-
gation seems to depend on the display of the protein in a specific
LPS core background. A series of Ail-expressing E. coli with pro-
gressively truncated LPS differ in flocculent growth and pellicle
formation (Figure 3) (Kolodziejek et al., 2010).
Y. pestis AIL IS A VIRULENCE FACTOR
Although Ail in Y. enterocolitica is present in all pathogenic strains
(Miller et al., 1989b), no changes in virulence are observed when
the gene is deleted (Wachtel and Miller, 1995). No information
regarding the role of Ail in Y. pseudotuberculosis virulence is avail-
able. In contrast, Ail in Y. pestis is a required virulence factor. Full
assessment of Ail’s role in Y. pestis pathogenesis requires use of
multiple animal models. Because murine serum is not bacterici-
dal for ail-negative Y. pestis, experiments with mice cannot fully
assess the role of serum resistance in plague pathogenesis and
studies in mice mostly reflect the role of adhesive/invasive phe-
notype of Ail. Rats make a better model of Y. pestis pathogenesis
since their serum is similar to humans in that it is bactericidal to
the ail mutant. Comparison of the mortality between the mice
and rats following Y. pestis challenge (see below) indicates that
serum resistance contributes to virulence more prominently than
bacterial association with the host cells. Other models, employing
Caenorhabditis elegans and fleas, have investigated the role of Ail
in virulence and flea transmission.
RAT MODEL OF PLAGUE
Ail is an essential virulence factor in the pneumonic (intranasal
infection) and bubonic (intradermal injection) model of plague
in rats (Kolodziejek et al., 2010; Hinnebusch et al., 2011). Deletion
of Ail completely attenuates virulence of Y. pestis CO92 in pneu-
monic model of infection; all rats challenged with the highest
dose of 1 × 108 CFU survive, vs. the LD50 of 1.2 × 103 CFU
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established for the wild-type strain (Kolodziejek et al., 2010).
Similarly, in a bubonic model of plague infection with up to
3 × 104 CFU of the Y. pestis CO92 ail-negative strain produce no
mortality and no signs of systemic plague morbidity, and most of
the animals have no Y. pestis cultured from their spleens 17–20
days after the infection (Hinnebusch et al., 2011). These obser-
vations are in contrast with animals infected with the wild-type
strain: a very small LD50 dose (Table 1) leads to death of the
animals within 2–5 days post injection. The presence of high wild-
type bacterial numbers in the spleen in late stages of infection
coupled with systemic signs of terminal disease likewise con-
trasts with the infection pattern of ail mutant. Interestingly, even
though the animals infected with the ail mutant do not show
other signs of morbidity (the animals remain alert and active)
they present enlarged lymph nodes that develop during the sec-
ond week post infection. The purulent lymphadenitis is never
observed in the rats infected with the wild-type in which the
buboes are characterized with (1) massive accumulation of bac-
teria within 3–5 days, (2) a hemorrhage, and (3) no signs of
pus or strong PMNL response. Meanwhile, ail-negative strain
develops buboes with the pronounced number of PMNLs; (1)
large abscesses encapsulating PMNLs and bacteria, (2) sterile and
resolving abscess’s with PMNLs, fibroblasts, macrophages, and
multinucleated giant cells, and (3) immunoglobulin-producing
plasma cells. All these features are evidence of the chronic inflam-
matory response induced by infections with the ail mutant that is
not seen with the wild-type (Hinnebusch et al., 2011).
MOUSE MODEL OF PLAGUE
In mouse models of pneumonic plague, deletion of Ail in Y. pestis
CO92 extends the time-to-death, but does not alter the LD50
value (Table 1). Overall, deletion of Ail delays 100% mortal-
ity rate by 24–48 h depending on the challenge dose (10 LD50
and 100 LD50, respectively) (Kolodziejek et al., 2010). In con-
trast, intradermal and intravenous (tail vein) infection with ail
mutants (in Y. pestis CO92 and Y. pestis KIM5, respectively) atten-
uates both strains and results in ∼103-fold increase in LD50
value (Table 1) (Felek and Krukonis, 2009; Hinnebusch et al.,
2011). The same KIM5 ail-negative strain inoculated via retro-
orbital route has no defect in virulence (Bartra et al., 2008). The
histopathological changes specific for mice infected with the ail
mutant include: (1) enlarged lymph nodes containing abscesses
and some puss (bubonic model) (Hinnebusch et al., 2011); (2)
increase in immune cell infiltration in spleen and liver tissues,
their damage, and spleen enlargement (septicemic model) (Felek
and Krukonis, 2009). Additionally, different kinetics of bacte-
rial colonization are found for the ail-negative strain in the
intravenous infection model. At the beginning of infection both
mutant and wild-type strains colonizes spleen, liver, and lung tis-
sue similarly, but as the infection progresses, the number of the
ailmutant bacteria retrieved from the tissues dramatically decline
(Felek and Krukonis, 2009).
Caenorhabditis elegans AND A FLEA MODEL OF Y. pestis
INFECTION
Ail is required for biofilm-independent killing of Caenorhabditis
elegans (Bartra et al., 2008) as its deletion increases survival of
adult worms infected with Y. pestis KIM5. However, even though
deletion of ail changes the autoaggregation phenotype in Y. pestis,
it does not affect biofilm-dependent killing of the nematode
(Bartra et al., 2008). Similarly, deletion of ail does not alter either
the infection rate or bacterial blockage of the flea (X. cheopsis)
necessary for effective plague transmission from a vector to a
mammalian host (Bartra et al., 2008).
AIL AS A POTENTIAL VACCINE CANDIDATE AGAINST
Y. pestis HUMAN INFECTIONS
Presently, there is no effective plague vaccine (Williamson, 2009).
Killed whole cells vaccines (known since late 1890’s) and a live
attenuated Y. pestis EV76 strain decrease the incidence but do
not provide long-lasting efficacious protection against bubonic
plague and provide no protection against the pneumonic form of
the disease. Additionally, severe side-effects can occur after vac-
cination. Therefore, the use of the killed whole cells vaccine was
discontinued in the United States in 1998 and at present no vac-
cine is available (Butler, 2009). With the biological threat and
appearance of drug resistant strains of Y. pestis, there have been
increased efforts to develop more effective vaccines to ensure full
protection especially against the aerosol-borne form of the disease
(Williamson, 2001, 2009). The surface-exposed localization of
Ail, the robust induction of inflammatory response in lymphoid
tissues caused by ail-negative strain, and Ail’s overall pronounced
role in virulence of this notorious pathogen make the protein a
good potential vaccine target. It has already been shown that rats
subcutaneously infected with the ailmutant have very high serum
antibody titers against Caf1 protein, indicative of a strong protec-
tive response against Y. pestis. Moreover, the persistent infection
in the lymph nodes uniquely generated by ail mutant in rats, and
not by other Y. pestis attenuated strains due to their rapid clear-
ance, can serve as an important tool in identifying key players of
Y. pestis infection and the potential elucidation of new vaccine
targets (Hinnebusch et al., 2011).
CONCLUDING REMARKS
The elements of Y. pestis pathogenesis are still being elucidated.
This review describes the current understanding of the role of
Ail protein in the course of infection. The explanations behind
its pronounced role are provided; (1) inhibition of bactericidal
properties of the complement, (2) attachment and Yop delivery
to host tissue, (3) prevention of PMNL recruitment to the lymph
nodes, (4) inhibition of inflammatory response (Kolodziejek
et al., 2007; Felek and Krukonis, 2009; Hinnebusch et al., 2011)
are the crucial phenotypes mediated by Ail. Also, some com-
parison to Ail phenotype in Y. enterocolitica and Y. pseudotu-
berculosis is made to illustrate differences that could potentially
contributed to the drastic change of the bacterial lifestyle that
resulted in a shift from an entero- to a vector-borne systemic
pathogen.
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